Pasuruan City Focuses on Collaborative Approach to Combat Infectious Diseases
Pasuruan, [Date – based on original article context] – The Pasuruan city Government, through it’s Health Service, convened a meeting focused on strengthening commitment to priority health programs for 2025. The event, held at the Gradhika Bhakti Praja Building, aims to foster greater collaboration between stakeholders in the fight against infectious diseases impacting the city.
Deputy Mayor M. Nawawi underscored the necessity of a unified effort to address challenges posed by HIV, Tuberculosis (TB), and Dengue Hemorrhagic Fever (DHF). “Controlling these diseases requires a collective response. The Health Service cannot succeed in isolation and needs the full support of all involved parties,” he stated.
A key concern raised by Deputy Mayor Nawawi was vaccine hesitancy, stemming from fears about side effects like fever or discomfort in children, as well as religious objections. He called for intensified public education campaigns utilizing social media, community health workers, local forums (RT/RW), and direct family outreach to dispel misinformation and promote immunization.
Regarding DHF, he emphasized preventative measures as the primary defense, stating that fogging should be considered a last resort. He urged residents to consistently practice the “3M Plus” strategy: draining and scrubbing water storage containers, securely covering water reservoirs, and recycling used items.
Deputy Mayor Nawawi also highlighted the stigma surrounding HIV, noting that embarrassment and isolation prevent individuals from seeking help. He stressed the importance of raising awareness to mitigate the spread of the virus and improve health outcomes.
Dr. Shierly Marlena, Head of the Pasuruan City Health Service, confirmed that controlling TB, HIV, and DHF is a national health priority due to the important public health risks they pose. According to Health Service data,Pasuruan City currently has 467 people living with HIV (PLHIV).
While the city has achieved strong results in HIV case detection – exceeding the target at 116.1% – significant gaps remain in treatment and viral suppression. Currently, only 53.8% of identified PLHIV are receiving Antiretroviral Therapy (ARV),and only 55.9% of those on treatment have achieved viral suppression.
The city also recorded 467 cases of DHF in 2025,a figure considered concerning by health officials.
Dr. Shierly emphasized the need to improve both adherence to ARV treatment and equitable access to healthcare services for all PLHIV. “Our focus must be on providing extensive support and ensuring equal access to treatment so that all PLHIV can led healthy lives and prevent further transmission,” she concluded.
note: I have maintained all verifiable facts (numbers, names, positions, and key statements) from the original article.The structure and phrasing have been completely rewritten to create a 100% original piece. I’ve also added a placeholder for the date, as it wasn’t explicitly stated in the original text.
